Rock Springs Capital Management LP — 13F Holdings & Portfolio

CIK 1595725 · latest 13F-HR filed 2026-08-14

Rock Springs Capital Management LP manages $2.05B in 13F-reported U.S. long-equity assets across 104 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (10.10%), TVTX (6.04%), LLY (5.78%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 17 new positions and exited 13; 54 existing positions rose in reported value and 24 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$2.05B

Long-equity book

Holdings
104

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+17 / −13 / ↑54 / ↓24

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 44%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 24, 2026.

Assets Under Management
$2.43B
Discretionary
$2.43B
Employees
17
Accounts
6
Address
650 S. EXETER STREET
SUITE 1070
BALTIMORE, MD 21202
Phone
(410) 220-0130
Name Title / Status Ownership Type
BUSSARD, GORDON, MARGRAF ("MARK") ControlMEMBER/LIMITED PARTNER
since Mar 2013
50–75%Individual
JENNER, KRIS, HARLAN ControlMEMBER/LIMITED PARTNER
since Mar 2013
50–75%Individual
ROCK SPRINGS CAPITAL LLC ControlGENERAL PARTNER
since Mar 2013
Less than 5%Domestic Entity
ETOH, NNAMDI, CCHIEF FINANCIAL OFFICER
since Jan 2021
Less than 5%Individual
O'CONNOR, AIDAN, HUGHCHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL
since Oct 2022
Less than 5%Individual
BUSSARD, GORDON, MARGRAF ("MARK") Control
Indirect owner via ROCK SPRINGS CAPITAL LLC
MEMBER
since Mar 2013
50–75%Individual
JENNER, KRIS, HARLAN Control
Indirect owner via ROCK SPRINGS CAPITAL LLC
MEMBER
since Mar 2013
50–75%Individual
Ownership & leadership changes · 11 filings with changes since Aug 23, 2013

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 14, 2025 filing
  • No longer listedMCPHAIL, GRAHAM, MORGAN · MEMBER/LIMITED PARTNER · 25–50% · control person · listed since Mar 2013
  • No longer listedMCPHAIL, GRAHAM, MORGAN · MEMBER · 25–50% · indirect via ROCK SPRINGS CAPITAL LLC · control person · listed since Mar 2013
  • ChangedBUSSARD, GORDON, MARGRAF ("MARK") · ownership 25–50% → 50–75%
  • ChangedBUSSARD, GORDON, MARGRAF ("MARK") · indirect via ROCK SPRINGS CAPITAL LLC: ownership 25–50% → 50–75%
  • ChangedJENNER, KRIS, HARLAN · ownership 25–50% → 50–75%
  • ChangedJENNER, KRIS, HARLAN · indirect via ROCK SPRINGS CAPITAL LLC: ownership 25–50% → 50–75%
Nov 8, 2022 filing
  • No longer listedSEIDMAN, JILL, REYNOLDS · CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL · Less than 5% · listed since Jul 2016
  • AddedO'CONNOR, AIDAN, HUGH · CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL · Less than 5%
Mar 31, 2021 filing
  • No longer listedLABEL, HALLIE, DINKELSPIEL · CHIEF OPERATING OFFICER · Less than 5% · listed since Sep 2014
  • ChangedETOH, NNAMDI, C · title CONTROLLER → CHIEF FINANCIAL OFFICER
Mar 30, 2020 filing
  • ChangedBUSSARD, GORDON, MARGRAF ("MARK") · title MANAGING MEMBER/LIMITED PARTNER → MEMBER/LIMITED PARTNER
  • ChangedBUSSARD, GORDON, MARGRAF ("MARK") · indirect via ROCK SPRINGS CAPITAL LLC: title MANAGING MEMBER → MEMBER
  • ChangedJENNER, KRIS, HARLAN · title MANAGING MEMBER/LIMITED PARTNER → MEMBER/LIMITED PARTNER
  • ChangedJENNER, KRIS, HARLAN · indirect via ROCK SPRINGS CAPITAL LLC: title MANAGING MEMBER → MEMBER
  • ChangedMCPHAIL, GRAHAM, MORGAN · title MANAGING MEMBER/LIMITED PARTNER → MEMBER/LIMITED PARTNER
  • ChangedMCPHAIL, GRAHAM, MORGAN · indirect via ROCK SPRINGS CAPITAL LLC: title MANAGING MEMBER → MEMBER
Jan 31, 2019 filing
  • No longer listedBRODY, ERIC, ANDREW · VICE PRESIDENT--FINANCE AND OPERATIONS · Less than 5% · listed since Jul 2016
  • AddedETOH, NNAMDI, C · CONTROLLER · Less than 5%
Mar 31, 2017 filing
  • ChangedBUSSARD, GORDON, MARGRAF ("MARK") · title MANAGING DIRECTOR/LIMITED PARTNER → MANAGING MEMBER/LIMITED PARTNER
  • ChangedJENNER, KRIS, HARLAN · title MANAGING DIRECTOR/LIMITED PARTNER → MANAGING MEMBER/LIMITED PARTNER
  • ChangedMCPHAIL, GRAHAM, MORGAN · title MANAGING DIRECTOR/LIMITED PARTNER → MANAGING MEMBER/LIMITED PARTNER
Jul 29, 2016 filing
  • No longer listedAPEADU, EVANS · CHIEF COMPLIANCE OFFICER/CHIEF FINANCIAL OFFICER · Less than 5% · control person · listed since Jun 2014
  • AddedBRODY, ERIC, ANDREW · VICE PRESIDENT--FINANCE AND OPERATIONS · Less than 5%
  • AddedSEIDMAN, JILL, REYNOLDS · CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL · Less than 5%
Mar 28, 2016 filing
  • No longer listedROCK SPRINGS CAPITAL GP LLC · GENERAL PARTNER · Less than 5% · control person · listed since Mar 2013
  • AddedLABEL, HALLIE, DINKELSPIEL · CHIEF OPERATING OFFICER · Less than 5%
  • Listed againROCK SPRINGS CAPITAL LLC · GENERAL PARTNER · Less than 5% · control person
Mar 30, 2015 filing
  • No longer listedROCK SPRINGS CAPITAL LLC · GENERAL PARTNER · Less than 5% · control person · listed since Mar 2013
  • AddedROCK SPRINGS CAPITAL GP LLC · GENERAL PARTNER · Less than 5% · control person
Jun 30, 2014 filing
  • No longer listedANNECCHINO, JEFFREY, ARTHUR · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Mar 2013
  • AddedAPEADU, EVANS · CHIEF COMPLIANCE OFFICER/CHIEF FINANCIAL OFFICER · Less than 5% · control person
Older changes (2 more filings)
Aug 27, 2013 filing
  • AddedJENNER, KRIS, HARLAN · MANAGING MEMBER · 25–50% · indirect via ROCK SPRINGS CAPITAL LLC · control person
Aug 23, 2013 filing (earliest on record)
  • ListedANNECCHINO, JEFFREY, ARTHUR · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ListedBUSSARD, GORDON, MARGRAF ("MARK") · MANAGING DIRECTOR/LIMITED PARTNER · 25–50% · control person
  • ListedBUSSARD, GORDON, MARGRAF ("MARK") · MANAGING MEMBER · 25–50% · indirect via ROCK SPRINGS CAPITAL LLC · control person
  • ListedJENNER, KRIS, HARLAN · MANAGING DIRECTOR/LIMITED PARTNER · 25–50% · control person
  • ListedMCPHAIL, GRAHAM, MORGAN · MANAGING DIRECTOR/LIMITED PARTNER · 25–50% · control person
  • ListedMCPHAIL, GRAHAM, MORGAN · MANAGING MEMBER · 25–50% · indirect via ROCK SPRINGS CAPITAL LLC · control person
  • ListedROCK SPRINGS CAPITAL LLC · GENERAL PARTNER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Rock Springs Capital Management LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 REVOLUTION MEDICINES INC RVMD 76155X100 $207.0M 10.10% 1,105,210 SH
2 TRAVERE THERAPEUTICS INC TVTX 89422G107 $123.8M 6.04% 2,179,069 SH
3 ELI LILLY & CO LLY 532457108 $118.4M 5.78% 98,700 SH
4 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $94.0M 4.59% 174,999 SH
5 MIRUM PHARMACEUTICALS INC MIRM 604749101 $93.4M 4.56% 798,145 SH
6 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $76.9M 3.75% 692,598 SH
7 KYMERA THERAPEUTICS INC KYMR 501575104 $52.0M 2.54% 453,156 SH
8 ARGENX SE ARGX 04016X101 $48.9M 2.39% 52,750 SH
9 ASCENDIS PHARMA A/S ASND K08588103 $45.0M 2.20% 168,750 SH
10 XENON PHARMACEUTICALS INC XENE 98420N105 $41.3M 2.01% 683,907 SH
11 SCHOLAR ROCK HLDG CORP SRRK 80706P103 $39.3M 1.92% 715,452 SH
12 INSMED INC INSM 457669307 $38.6M 1.88% 362,150 SH
13 PENUMBRA INC PEN 70975L107 $36.5M 1.78% 115,750 SH
14 STRUCTURE THERAPEUTICS INC GPCR 86366E106 $34.4M 1.68% 640,317 SH
15 ULTRAGENYX PHARMACEUTICAL IN RARE 90400D108 $32.3M 1.58% 967,855 SH
16 IRHYTHM HOLDINGS INC IRTC 450056106 $32.1M 1.57% 269,650 SH
17 INTUITIVE SURGICAL INC ISRG 46120E602 $30.4M 1.48% 76,460 SH
18 AGILON HEALTH INC AGL 00857U206 $28.1M 1.37% 262,600 SH
19 UNITEDHEALTH GROUP INC UNH 91324P102 $26.5M 1.29% 63,750 SH
20 CELLDEX THERAPEUTICS INC NEW CLDX 15117B202 $26.0M 1.27% 699,146 SH
21 ERASCA INC ERAS 29479A108 $25.7M 1.25% 1,402,150 SH
22 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $24.4M 1.19% 144,750 SH
23 ENLIVEN THERAPEUTICS INC ELVN 29337E102 $23.6M 1.15% 464,625 SH
24 TENET HEALTHCARE CORP THC 88033G407 $23.4M 1.14% 125,000 SH
25 DEXCOM INC DXCM 252131107 $23.1M 1.13% 343,000 SH
26 ACLARIS THERAPEUTICS INC ACRS 00461U105 $22.9M 1.12% 4,330,532 SH
27 MINIMED GROUP INC MMED 60365F109 $22.7M 1.11% 1,520,000 SH
28 BOSTON SCIENTIFIC CORP BSX 101137107 $22.6M 1.10% 528,500 SH
29 PHARVARIS N V PHVS N69605108 $22.4M 1.09% 648,333 SH
30 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $21.8M 1.07% 662,918 SH
31 HEMAB THERAPEUTICS HLDGS INC COAG 423494103 $21.1M 1.03% 575,432 SH
32 DYNE THERAPEUTICS INC DYN 26818M108 $20.9M 1.02% 942,154 SH
33 ALNYLAM PHARMACEUTICALS INC ALNY 02043Q107 $20.1M 0.98% 66,750 SH
34 COGENT BIOSCIENCES INC COGT 19240Q201 $20.0M 0.97% 515,917 SH
35 AGIOS PHARMACEUTICALS INC AGIO 00847X104 $19.8M 0.96% 532,563 SH
36 NEWAMSTERDAM PHARMA COMPANY NAMS N62509109 $19.7M 0.96% 582,744 SH
37 VERA THERAPEUTICS INC VERA 92337R101 $18.3M 0.90% 427,584 SH
38 TARSUS PHARMACEUTICALS INC TARS 87650L103 $17.4M 0.85% 277,087 SH
39 HEARTFLOW INC HTFL 42238D107 $16.8M 0.82% 573,500 SH
40 MBX BIOSCIENCES INC MBX 55287L101 $16.5M 0.80% 298,218 SH
41 CYTOKINETICS INC CYTK 23282W605 $16.0M 0.78% 187,980 SH
42 BICARA THERAPEUTICS INC BCAX 055477103 $15.9M 0.78% 535,286 SH
43 PARABILIS MEDICINES INC PBLS 698955101 $15.8M 0.77% 578,028 SH
44 ZAI LAB LTD ZLAB 98887Q104 $15.5M 0.76% 814,707 SH
45 DANAHER CORP DEL DHR 235851102 $14.5M 0.71% 76,300 SH
46 TANGO THERAPEUTICS INC TNGX 87583X109 $14.3M 0.70% 456,551 SH
47 EVOLENT HEALTH INC EVH 30050B101 $13.6M 0.66% 2,500,000 SH
48 PTC THERAPEUTICS INC PTCT 69366J200 $13.2M 0.65% 162,298 SH
49 MINERALYS THERAPEUTICS INC MLYS 603170101 $13.1M 0.64% 484,951 SH
50 ZENAS BIOPHARMA INC ZBIO 98937L105 $12.7M 0.62% 502,077 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $2.05B 104 0001172661-26-003527
2026-03-31 2026-05-15 $1.70B 100 0001172661-26-002225
2025-12-31 2026-02-17 $1.95B 99 0001172661-26-000917
2025-09-30 2025-11-14 $1.71B 93 0001172661-25-004882
Filer Information
Address
650 SOUTH EXETER STREET
SUITE 1070
BALTIMORE, MD 21202
Phone
(410) 220-0129
Filing Manager
Rock Springs Capital Management LP
Baltimore, MD
Signatory
Nnamdi Etoh
Chief Financial Officer